New technologies are transforming optometric practice at an unprecedented pace – from OCT and ultra-widefield imaging to AI-assisted diagnostics, dry eye platforms and myopia management devices.

Karl Jeebaun is Director of the Optical Suppliers Association and Chair of E-Health within the organisation, and Group CEO of SPARCA, which builds software and AI systems. One of the companies within that group is Advanced Ophthalmic Systems, which builds for retail optics and clinical research within ophthalmology.   

He says that, globally, technology is “outpacing regulations everywhere. The impact on optics in the next 18 months will be seismic in what can be done remotely, what can be done autonomously, and how it can change the way an independent or high-street practice operates.” 

Drew Thompson MCOptom, owner of Thompson & Hardwick Optometrists in Lytham St Anne’s, says it is an “exciting time” for new technology: it is “making it easier to give a much more varied and comprehensive service to my patients”.  

Often new technologies are marketed with bold claims of improved outcomes, efficiency and profitability. But not all innovation translates into meaningful clinical or business value.